A Study to Determine the Risk of Cancer in Rheumatoid Arthritis (RA) Patients Who Use Abatacept and Other Biologic Agents

Benefits of Injectable Abatacept Using Magnetic Resonance Imaging (MRI) in Rheumatoid Arthritis (RA) Patients

NCT01351480 ·Status: COMPLETED ·Phase: PHASE3

Safety Study of Abatacept to Treat Rheumatoid Arthritis

NCT01247766 ·Status: COMPLETED

Effects of Abatacept in Patients With Early Rheumatoid Arthritis

NCT02504268 ·Status: COMPLETED ·Phase: PHASE3

A Study of Juvenile Idiopathic Arthritis Patients Given Abatacept and the Number of Infections or Malignancies That Occur

NCT03769558 ·Status: COMPLETED

A Study to Evaluate Biomarkers to Predict Efficacy of Abatacept in Rheumatoid Arthritis

NCT03882008 ·Status: COMPLETED ·Phase: PHASE4

Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients

NCT00124449 ·Status: COMPLETED ·Phase: PHASE2

An Exploratory Study of Changes in Synovial Immune Responses Following BMS-188667 Therapy in Subjects With Active Rheumatoid Arthritis on Background DMARDs Who Have Failed Anti-TNF Therapy

NCT00162201 ·Status: COMPLETED ·Phase: PHASE1

Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid Arthritis

NCT02557100 ·Status: COMPLETED ·Phase: PHASE4

A Retrospective Observational Study on the Use of Biologics in Monotherapy in Patients With Rheumatoid Arthritis

NCT01834807 ·Status: COMPLETED

Predictors of Response to Tofacitinib Treatment in Rheumatoid Arthritis Patients

NCT04079920 ·Status: COMPLETED

Safety Study of Abatacept to Treat Rheumatoid Arthritis (A)

NCT01088321 ·Status: COMPLETED

Post-marketing Study Assessing the Long-Term Safety of Abatacept

NCT02169544 ·Status: COMPLETED

A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis

NCT00048932 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis

NCT01142726 ·Status: COMPLETED ·Phase: PHASE3

Does Abatacept Induce Regulatory B Cells in Patients With Rheumatoid Arthritis

NCT02885818 ·Status: COMPLETED

Abatacept With Methotrexate- Phase IIB

NCT00162266 ·Status: COMPLETED ·Phase: PHASE2

A Study to Compare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive, and Shared Epitope-positive Rheumatoid Arthritis and an Inadequate Response to Methotrexate

NCT04909801 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Effects of Abatacept on Myocarditis in Rheumatoid Arthritis

NCT03619876 ·Status: TERMINATED ·Phase: PHASE4

Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Rheumatoid Arthritis

NCT00650026 ·Status: APPROVED_FOR_MARKETING

Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting

NCT02037737 ·Status: COMPLETED

Phase IIIB Subcutaneous Abatacept Monotherapy Study

NCT00547521 ·Status: COMPLETED ·Phase: PHASE3

Remission and Joint Damage Progression in Early Rheumatoid Arthritis

NCT00122382 ·Status: COMPLETED ·Phase: PHASE3

Study on the Safety of Abatacept in Relapsing Polychondritis

NCT01272856 ·Status: COMPLETED ·Phase: PHASE1

A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate

NCT00420199 ·Status: COMPLETED ·Phase: PHASE3

A Phase III Study of Abatacept in Japanese Subjects With Rheumatoid Arthritis

NCT00484289 ·Status: COMPLETED ·Phase: PHASE3